Nghiên cứu tác dụng của viên nang "Hạ mỡ NK" trên bệnh nhân rối loạn chuyển hoá lipid máu tại bệnh viện Đại học Y Hải Phòng năm 2022

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Thị Nhi Vũ

Ngôn ngữ: vie

Ký hiệu phân loại:

Thông tin xuất bản: Tạp chí Khoa học Sức khỏe, 2024

Mô tả vật lý: tr.100

Bộ sưu tập: Metadata

ID: 341928

Thêm vào giỏ Liên kết toàn văn

Mục tiêu: Đánh giá hiệu quả điều trị của viên nang "Hạ mỡ NK" trên bệnh nhân Rối loạn chuyển hoá lipid máu (RLLPM).2 Đánh giá tác dụng của viên nang "Hạ mỡ NK" trên bệnh nhân có chứng Đàm theo Y học cổ truyền tại Bệnh viện Đại học Y Hải Phòng năm 2022. Phương pháp: Nghiên cứu quan sát lâm sàng so sánh trước – sau điều trị trên 45 bệnh nhân được chẩn đoán Rối loạn chuyển hóa Lipid máu tại Bệnh viên đại học y Hải Phòng. Kết quả: Viên nang "Hạ mỡ NK" có tác dụng cải thiện các chỉ số TC và LDL – C, có kết quả giảm lần lượt là 5,88% và 8,01% với p<
0,05. Hiệu quả điều trị chung sau 30 ngày điều trị là 68.9% có hiệu quả tốt, 26.7% ở hiệu quả khá, có 4.4% không hiệu quả và 0% hiệu quả xấu và không thấy có tác động không mong muốn nên chỉ số huyết học và chức năng gan – thận. Hiệu quả điều trị trên chứng Đàm theo Y học cổ truyền là đạt tốt 15.6%, đạt khá 28.9%, không hiệu quả (mức cải thiện triệu chứng ≤ 30%) đạt 55.6% và 0% hiệu quả xấu. Như vậy, viên nang “Hạ mỡ NK” không chỉ có tác dụng giảm các chỉ số lipid máu còn làm giảm nhẹ các triệu chứng gây ra bới chứng Đàm YHCT.Objectives: To evaluate the treatment effectiveness of “Ha mo NK” capsules on dyslipidemia patients at Hai Phong Medical University Hospital in 2022. And to evaluate the effect of “Ha mo NK” capsules on phlegm syndromes for dyslipidemia patients. Method: Clinical trial study, comparing the before and after treatment, control comparisons of 45 patients who were diagnosed with dyslipidemia. Results: “Ha mo NK” capsules improved TC and LDL – C indices, which resulted in reductions of 5.88% and 8.01% with p<
0.05. After 30 days of treatment, the overall treatment effect was 68.9% good, 26.7% quite, 4.4% inefficient, and 0% bad effect. There was no side effects on the hematological indices and liver–kidney function. According to Traditional Medicine, the treatment effect of phlegm Syndrome was 15.6% good, 28.9% quite, 55.6% inefficient (symptom improvement ≤ 30%) and 0% bad effect. Thus, the capsule "Ha mo NK" not only has the effect of reducing blood lipid indexes but also alleviates the symptoms caused by dyslipidemia.

1. Đọc trực tuyến

1. Đọc trực tuyến

Tạo bộ sưu tập với mã QR